Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolomics and Diabetes: Analytical and Computational Approaches
Kelli M. Sas, Alla Karnovsky, George Michailidis, et al.
Diabetes (2015) Vol. 64, Iss. 3, pp. 718-732
Open Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

Quality assurance procedures for mass spectrometry untargeted metabolomics. a review
Danuta Dudzik, Cecilia Barbas-Bernardos, Antonia Garcı́a, et al.
Journal of Pharmaceutical and Biomedical Analysis (2017) Vol. 147, pp. 149-173
Closed Access | Times Cited: 305
Evaluation and comparison of bioinformatic tools for the enrichment analysis of metabolomics data
Anna Marco‐Ramell, Magalí Palau‐Rodriguez, Ania Alay, et al.
BMC Bioinformatics (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 208
Metabolomics of Type 1 and Type 2 Diabetes
Borros Arneth, Rebekka Arneth, Mohamed E. E. Shams
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2467-2467
Open Access | Times Cited: 206
An overview of renal metabolomics
Sahir Kalim, Eugene P. Rhee
Kidney International (2016) Vol. 91, Iss. 1, pp. 61-69
Open Access | Times Cited: 144
Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention
Ruth F. Dubin, Eugene P. Rhee
Clinical Journal of the American Society of Nephrology (2019) Vol. 15, Iss. 3, pp. 404-411
Open Access | Times Cited: 141
Metabolic signatures and risk of type 2 diabetes in a Chinese population: an untargeted metabolomics study using both LC-MS and GC-MS
Yonghai Lu, Yeli Wang, Choon Nam Ong, et al.
Diabetologia (2016) Vol. 59, Iss. 11, pp. 2349-2359
Open Access | Times Cited: 140
Metabolomics Signatures in Type 2 Diabetes: A Systematic Review and Integrative Analysis
Yue Sun, Haoyu Gao, Zhiyuan Fan, et al.
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 105, Iss. 4, pp. 1000-1008
Open Access | Times Cited: 128
High-Coverage Targeted Lipidomics Reveals Novel Serum Lipid Predictors and Lipid Pathway Dysregulation Antecedent to Type 2 Diabetes Onset in Normoglycemic Chinese Adults
Jieli Lu, Sin Man Lam, Qin Wan, et al.
Diabetes Care (2019) Vol. 42, Iss. 11, pp. 2117-2126
Open Access | Times Cited: 125
Metabolomics and Its Application to Acute Lung Diseases
Kathleen A. Stringer, Ryan T. McKay, Alla Karnovsky, et al.
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 110
Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy
Sang Youl Rhee, Eun Sung Jung, Hye Min Park, et al.
Metabolomics (2018) Vol. 14, Iss. 7
Open Access | Times Cited: 107
The pathogenesis and pathophysiology of gestational diabetes mellitus: Deductions from a three-part longitudinal metabolomics study in China
Kai P. Law, Hua Zhang
Clinica Chimica Acta (2017) Vol. 468, pp. 60-70
Closed Access | Times Cited: 99
Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
Monika A. Niewczas, Anna V. Mathew, Stephanie Croall, et al.
Diabetes Care (2017) Vol. 40, Iss. 3, pp. 383-390
Open Access | Times Cited: 96
Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease
Judy Baek, Chenchen He, Farsad Afshinnia, et al.
Nature Reviews Nephrology (2021) Vol. 18, Iss. 1, pp. 38-55
Open Access | Times Cited: 96
Metabolomics in diabetic complications
Laura A. Filla, James L. Edwards
Molecular BioSystems (2016) Vol. 12, Iss. 4, pp. 1090-1105
Open Access | Times Cited: 92
Evaluation of coverage, retention patterns, and selectivity of seven liquid chromatographic methods for metabolomics
Stefanie Wernisch, Subramaniam Pennathur
Analytical and Bioanalytical Chemistry (2016) Vol. 408, Iss. 22, pp. 6079-6091
Open Access | Times Cited: 89
Metabolomic and Lipidomic Signatures of Metabolic Syndrome and its Physiological Components in Adults: A Systematic Review
Stéphanie Monnerie, Blandine Comte, Daniela Ziegler, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 88
Porcine models for studying complications and organ crosstalk in diabetes mellitus
Simone Renner, Andreas Blutke, Sebastian Clauß, et al.
Cell and Tissue Research (2020) Vol. 380, Iss. 2, pp. 341-378
Closed Access | Times Cited: 74
Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort
Farsad Afshinnia, Thekkelnaycke M. Rajendiran, Alla Karnovsky, et al.
Kidney International Reports (2016) Vol. 1, Iss. 4, pp. 256-268
Open Access | Times Cited: 81
Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes
Nete Tofte, Tommi Suvitaival, Linda Ahonen, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 74
Arabinoxylan Attenuates Type 2 Diabetes by Improvement of Carbohydrate, Lipid, and Amino Acid Metabolism
Qixing Nie, Haihong Chen, Jielun Hu, et al.
Molecular Nutrition & Food Research (2018) Vol. 62, Iss. 20
Closed Access | Times Cited: 70
Metabolomics reveal mitochondrial and fatty acid metabolism disorders that contribute to the development of DKD in T2DM patients
Ling Li, Chengshi Wang, Hongliu Yang, et al.
Molecular BioSystems (2017) Vol. 13, Iss. 11, pp. 2392-2400
Closed Access | Times Cited: 68
Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study
Brian Kwan, Tobias Fuhrer, Jing Zhang, et al.
American Journal of Kidney Diseases (2020) Vol. 76, Iss. 4, pp. 511-520
Open Access | Times Cited: 65
What Have Metabolomics Approaches Taught Us About Type 2 Diabetes?
Alba González-Franquesa, Alison Burkart, Elvira Isganaitis, et al.
Current Diabetes Reports (2016) Vol. 16, Iss. 8
Open Access | Times Cited: 64
NMR-based metabolomics strategies: plants, animals and humans
João Guilherme de Moraes Pontes, Antonio Jadson Marreiro Brasil, Guilherme Cruz, et al.
Analytical Methods (2017) Vol. 9, Iss. 7, pp. 1078-1096
Closed Access | Times Cited: 64
Plasma metabolites associated with type 2 diabetes in a Swedish population: a case–control study nested in a prospective cohort
Lin Shi, Carl Brunius, Marko Lehtonen, et al.
Diabetologia (2018) Vol. 61, Iss. 4, pp. 849-861
Open Access | Times Cited: 63
Page 1 - Next Page

Scroll to top